AdvaMed Highlights Access Concerns in CMS 2026 Home Health Payment Rule
AdvaMed responds to CMS 2026 payment rule, stressing patient access to diabetes and prosthetic supplies amid competitive bidding concerns.
AdvaMed responds to CMS 2026 payment rule, stressing patient access to diabetes and prosthetic supplies amid competitive bidding concerns.
The 2026 Medicare home health final rule release is delayed due to the government shutdown. Proposed 9% reimbursement cuts spark industry-wide concern and strategic responses from key providers and advocacy groups.
CMS proposes a 6.4% cut in 2026 Medicare payments to home health agencies, driven by PDGM budget neutrality adjustments and expanding Medicare Advantage enrollment. HHAs must assess financial impacts, advocate, and optimize operations.
CMS 2026 outpatient rule proposes major changes including inpatient-only list elimination and expanded ambulatory surgery center procedures, impacting Medicare payment and compliance.
OIG audit finds $100,696 in Medicare overpayments to HRS Home Health, highlighting compliance challenges in home health billing and the impact of CMS oversight.
Study reveals shifting patterns in home health care use among Medicare Advantage enrollees, highlighting implications for care quality, equity, and policy in U.S. Medicare programs.
The National Alliance for Care at Home criticizes MedPAC's recommendations affecting home health and hospice services, highlighting risks to patient care.